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or pituitary function rather than testicular function in male rats. The potential role 
of	hCG	as	a	cheap,	safe	and	readily	available	treatment	for	reversing	surgery	or	TBI-	
induced hypogonadism is discussed.
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1  |  INTRODUC TION
Traumatic	brain	injury	(TBI)	is	a	major	public	health	problem1 due to 
the	 relatively	high	 incidence	 rate	 (106	per	100,000	globally),2 and 
the	 lack	 of	 effective	 treatments.	 The	 incidence	 of	 TBI	 in	males	 is	
3	times	that	of	females,	but	normalizes	to	1:1	by	age	65.3 The con-
sequences	of	a	TBI	can	 include	functional	 (eg	decreased	cognitive	
performance),	 psychopathological	 (eg	 post-	traumatic	 stress	 disor-












this	 protein	 has	 well-	defined	 neurogenic	 properties,21–	26 our data 






its development into a blastocyst.27,28 hCG mediated these effects via 
the	upregulation	of	steroidogenesis	 (P4 synthesis); P4 signalling was 
found	to	be	obligatory	for	both	embryoid	body	(aka	morula)	and	neu-
roectodermal	rosette	(aka	primitive	neural	tube)	formation.
In	addition	 to	hCG's	 role	 in	early	embryonic	and	brain	develop-
ment,27	hCG	and	its	adult	homolog	luteinizing	hormone	(LH)	promote	
neuronal	 proliferation,29	while	 hCG	and	 sex	 steroids	 regulate	 adult	
neuronal	differentiation	(ie	neuritogenesis,	spine	density,	synaptogen-
esis).30,31	Conversely,	age-	related	or	age-	induced	reproductive	endo-
crine dyscrasia	has	a	negative	impact	on	cognitive	function,32 an effect 
that can be slowed or halted by the partial rebalancing of the HPG 
axis	with	sex	steroid	supplementation33,34	or	gonadotropin-	releasing	
hormone	(GnRH)	superagonist	and	antagonist	treatment.35 HH could 
therefore greatly compromise cognitive performance and neurore-
generation	following	a	TBI.	Importantly,	hCG	has	been	shown	to	im-
prove	functional	recovery	following	spinal	cord	 injury	 in	rats,30,36,37 
and decrease ischaemic brain injury in adult and neonatal rodent 
models of stroke.38–	40	Aside	from	these	neuroprotectant	properties,	
hCG also promotes neurite sprouting and neuron survival.40
TBI-	induced	HH	 is	 thought	 to	 result	 from	damage	 to	 the	 hypo-
thalamus or pituitary41,42	 and/or	 stress-	induced	 cortisol-	mediated	
suppression	of	the	HPG	axis.43,44	While	prevalence	rates	for	HH	vary	
widely,	 likely	 due	 to	 the	 severity	 of	 the	 injury,	 location	 and	 type	of	
injury,	 time	of	screening	and	design	of	 the	study,	 there	 is	 increasing	
consensus	 that	even	mild	TBIs	can	 induce	HH	and	 that	 severe	TBIs	
induce persistent HH.6,14,45–	47 This silent condition goes mostly undi-
agnosed	and	therefore	untreated.	Based	on	the	pleiotropic	properties	
of	hCG,	in	this	study	we	tested	whether	hCG	treatment	could	reverse	








vironment over 2 days. Rats were then weighed and handled for no less 
than	5	min.	each	for	5	consecutive	days	and	daily	thereafter	while	being	










~15-	 to	30-	min	duration;	 craniectomy	+CCI	 injury	~25-	 to	45-	min	
duration).	 An	 anaesthesia	 chamber	was	 used	 for	 induction,	 and	 a	
nose cone was used for maintenance.
2.2.1  |  Controlled	cortical	impact	and	
sham surgeries
Anaesthetized	 rats	 were	 mounted	 in	 a	 Kopf	 stereotaxic	 device	
(Model	 900),	 where	 the	 animal's	 head	 was	 held	 in	 place	 by	 non-	
traumatic	 ear	 bars	 and	 a	 bite	 bar.	 Anaesthesia	 was	 maintained	
by	 nose	 cone	while	 the	 head	was	 shaved	 and	 sterilized	with	70%	
ethanol	 and	 Betadine™	 (Purdue	 Products	 L.P.)	 antiseptic	 solution.	
Throughout	surgery,	anaesthesia	levels	were	monitored	closely	and	
K E Y W O R D S
human	chorionic	gonadotropin,	hypoadrenalism,	hypogonadism,	RU-	486,	testosterone,	
traumatic brain injury
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were	frequently	adjusted	as	needed,	based	on	heart	rate,	respiration	
rate	 and	 oxygen	 saturation.	 A	 homeothermic	 blanket	 control	 unit	
(Harvard	Apparatus,	Holliston,	MA)	was	used	to	monitor	body	tem-




6-	mm-	diameter	 craniectomy	was	 centred	on	 the	midline	 at	 2.5	mm	
anterior to β.	The	cortical	 impact	was	made	at	2.5	mm	anterior	to	β 
over	 the	midline	 of	 the	medial	 frontal	 cortex	with	 an	 Impact	One™	
Stereotaxic	CCI	 instrument	 (Leica),	using	a	5	mm	 impactor	 (bit	 size),	
travelling	 at	2.25	m/s	 (velocity),	 extending	3	mm	below	 the	 cortical	
surface	(impact	depth)	for	100	ms	(dwell	time).	Sham-	injured	groups	
received the same surgical procedures up to and including craniectomy 
but	no	CCI	injury.	After	surgery,	the	rats	were	placed	on	a	heating	pad,	
monitored closely and upon awakening were tested 30 min later for 
righting	reflex	to	assess	any	immediate	effects	of	craniectomy	or	CCI	
injury	on	righting	ability,	and	then	returned	to	their	home	cages.
2.3  |  Experimental design
Once	out	of	quarantine	all	rats	were	weighed	and	handled	for	one	
week.	The	final	body	weights	at	the	end	of	this	week	were	(1)	ranked	
from	highest	 to	 lowest	 (as	a	 function	of	age)	and	 then	 (2)	used	 to	






craniectomy	or	CCI,	Pregnyl®	 (hCG,	400	 IU/kg;	Merck	&	Co.,	 Inc.)	
or	 saline	 (0.9%	NaCl	 in	 deionized	H2O;	 equivalent	 volume	 to	 that	
injected for hCG) was injected intramuscularly every other day for 
29 days. Pregnyl®	is	a	highly	purified	pyrogen-	free	preparation	ob-
tained	from	the	urine	of	pregnant	females.	Each	vial	contains	10,000	
USP	 units	 of	 sterile	 dried	 powder	 with	 5	 mg	 monobasic	 sodium	
phosphate and 4.4 mg dibasic sodium phosphate that is diluted in 








hCG or saline control injection.
2.4  |  Blood collection and hormone analyses
Rats	were	anaesthetized	(between	9:00	a.m.–	12:00	noon)	and	their	
tails	 placed	 in	 a	 200-	ml	 beaker	 filled	with	warm	water	 (≤44°C)	 for	
5	min.	The	 tail	was	cleaned	with	70%	alcohol,	 the	minimal	 amount	
of	the	tail	 tip	snipped	with	a	blade,	and/or	the	wound	reopened	by	
removal	of	the	scab	for	subsequent	bleeds,	and	~1	ml	of	whole	blood	





blood was immediately centrifuged at 4000 g for 10– 20 min. and 




testosterone	 (T),	 11-	deoxycorticosterone	 (11-	DOC)	 and	 corticos-
terone adapted from a method previously described.48,49	Briefly,	 to	




a	 second	 dichloromethane	 extraction	 was	 performed.	 The	 organic	
phase was transferred into a clean test tube and evaporated to dry-
ness	and	 reconstituted	 in	mobile	phase.	Samples	were	analysed	on	
a	 QTRAP	 5500	 quadruple	 linear	 ion	 trap	 mass	 spectrometer	 (AB	
Sciex)	 equipped	 with	 an	 atmospheric	 pressure	 chemical	 ionization	
source.	The	system	includes	two	Shimadzu	LC20ADXR	pumps	and	a	
Shimadzu	SIL20ACXR	autosampler.	A	 sample	of	30	μl was injected 
onto	a	Phenomenex	Kinetex	2.6u	C18	100A,	100	×	2.1	mm	column	
(Torrance,	CA)	 for	 separation	using	 a	mobile	phase:	water	with	1%	
formic	acid	(Solution	A)	and	acetonitrile	with	1%	formic	acid	(Solution	
B),	at	a	flow	rate	of	200	μl/min. Quantitative results were recorded as 
multiple	reaction	monitoring	(MRM)	area	counts	after	determination	
for	the	response	factor	for	each	compound	and	internal	standard.	Each	
steroid had a MRM used for quantitation and 1 or 2 additional MRMs 









analyses were performed using the Tukey multiple comparison test. 
Independent	 paired	 t tests were also used to compare the differ-
ences	between	baseline	(pre-	injury)	and	post-	injury	data	when	data	
were	normally	distributed.	Hormone	data	collected	on	post-	surgery	
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(PSD)	or	post-	injury	 (PID)	days	were	analysed	using	 the	R	 statisti-
cal	program,	V.3.4.1	(R:	A	language	and	environment	for	statistical	
computing	 (program),	Vienna,	Austria:	R	Foundation	 for	Statistical	
Computing,	 2008),	 with	 package	 ‘rmcorr’	 (rmcorr:	 repeated-	





3.1  |  Craniectomy and controlled cortical impact 
injury induce hypogonadism and hypoadrenalism
ANOVA	 indicated	 a	 significant	 main	 effect	 of	 treatment	 for	 T	
(F(3,82)	 =	 14.35,	 p	 <	 .0001),	 P4	 (F(3,80)	 =	 11.34,	 p	 <	 .0001),	 11-	
DOC	(F(3,88)	=	9.27,	p	<	.0001)	and	corticosterone	(F(3,88)	=	24.98,	
p	<	 .0001).	A	main	effect	of	day	was	found	for	P4	 (F(3,80)	=	5.26,	
p	 =	 .0023),	 but	 not	 for	 T	 (F(3,82)	 =	 1.02,	 p	 =	 .386),	 11-	DOC	




Sham	 surgery	 (craniectomy	 +	 saline	 group)	 in	 male	 adult	 rats	
induced a decline from baseline in the circulating concentrations 
of	T	(79.1%;	7.5	±	1.5	ng/ml	to	1.6	±	0.3	ng/ml;	p	<	 .05),	P4	 (61.6%;	
9.0	 ±	 3.8	 ng/ml	 to	 3.5	 ±	 0.7	 ng/ml;	 p	 =	 .061),	 11-	DOC	 (46.6%;	
338.3	±	55.8	ng/ml	to	180.7	±	3.3	ng/ml,	p	<	.05)	and	corticosterone	
(56.2%;	218.7	±	24.5	ng/ml	 to	95.9	±	2.2	 ng/ml,	p	 <	 .05)	 by	PSD1	
(Figure	1).52	Similar	declines	in	circulating	concentrations	of	T	(80.0%,	
1.5	±	0.4	ng/ml,	p	<	 .01),	P4	 (56.8%,	3.9	±	1.4	ng/ml;	p	=	 .065),	11-	
DOC	(48.4%,	174.5	±	19.4	ng/ml;	p	<	.05)	and	corticosterone	(32.5%,	
147.7	±	17.4	ng/ml;	p	<	.05)	were	observed	by	PID	1	for	CCI-	injured	
animals	 (ie	 craniectomy	+	CCI	+	 saline	group),	 indicating	 that	Sham	
surgery alone was sufficient to induce hypogonadotropic hypogo-
nadism	(Figure	1A,B)	and	hypoadrenalism	(Figure	1C,D).52 Circulating 
concentrations	for	all	hormones	in	both	Sham	surgery	and	CCI-	injured	





sults	 suggest	 that	 sham	 surgery,	 and	 sham	 surgery	 plus	 a	 bilateral	
moderate-	to-	severe	CCI	injury,	induces	hypogonadism	in	rats.
3.2  |  hCG reverses craniectomy and CCI- induced 
hypogonadism and attenuates hypoadrenalism
hCG	 treatment	 of	 animals	 that	 underwent	 a	 craniectomy	 (Sham	
surgery)	 or	 craniectomy	 plus	 CCI	 injury	 (CCI	 group)	 significantly	
increased circulating concentrations of T and P4 back to baseline 
concentrations	 by	 PSD/PID	 1	 (Figure	 1A,B).	 Unlike	 P4,	 elevations	
in	T	were	maintained	through	PSD/PID	29.	While	a	significant	main	
effect of treatment group for androstenedione concentration also 
was	identified,	post	hoc	analyses	determined	that	androstenedione	
concentration	was	only	elevated	on	PID	11	in	the	CCI	+hCG	group	
F I G U R E  1 hCG	reverses	CCI-	induced	
decreases in circulating testosterone and 








analyses were performed using the Tukey 
multiple	comparison	test	(p	<	.05;	letters	





















































































































































can reverse hypogonadism induced by a craniectomy or a craniec-
tomy	+CCI	injury,	but	has	lesser	effect	on	reversing	hypoadrenalism.
3.3  |  RU- 486 diminishes craniectomy + CCI- 
induced hypoadrenalism
ANOVA	 indicated	 a	 significant	 main	 effect	 of	 treatment	 for	 T	
(F(3,71)	=	3.76,	p	 =	 .0145),	 P4	 (F(3,61)	=	5.82,	p	 =	 .0011),	 11-	DOC	
(F(3,61)	 =	 3.66,	 p	 =	 .0171),	 and	 corticosterone	 (F(3,61)	 =	 5.41,	
p	=	 .0023).	A	main	effect	of	day	was	 found	 for	P4	 (F(3,61)	=	5.82,	
p	 =	 .0015)	 and	 corticosterone	 (F(3,61)	 =	3.38,	p	 =	 .0238),	 but	 not	
for	T	(F(3,71)	=	1.86,	p	=	.145)	or	11-	DOC	(F(3,61)	=	1.80,	p	=	.158).	
No	main	 effects	 of	 treatment	 ×	 day	 interaction	were	 found	 for	 T	
(F(9,71)	 =	 0.33,	 p	 =	 .965),	 P4	 (F(9,61)	 =	 1.09,	 p	 =	 .3838),	 11-	DOC	
(F(9,61)	=	0.54,	p	=	.836)	or	corticosterone	(F(9,61)	=	0.65,	p	=	.750).
Pretreatment	 of	 animals	with	 RU-	486,	 a	 P4 receptor and gluco-
corticoid	 receptor	 antagonist,	 had	 little	 effect	 on	 Sham	 +hCG	 ani-















3.4  |  Relationships between circulating steroid 
concentrations before and after sham surgery, CCI 
injury and hCG treatment
Correlation analyses demonstrated strong positive correlations in 
baseline plasma samples between P4	with	androstenedione	(r	=	.84,	
p <	.01),	androstenedione	with	its	metabolite	T	(r	=	.82,	p < .01) and 
with	 corticosterone	 and	 its	 precursor	 11-	DOC	 (r	 =	 .89,	 p < .001; 
Table	1).	Sham	injury	obviated	the	significant	correlations	between	
sex	 steroids,	 but	 not	 corticosterone	 and	 its	 precursor	 11-	DOC	
(r	=	0.98,	p	<	.001,	Table	2).	hCG	treatment	of	Sham	animals	was	suf-
ficient in restoring the strong positive relationship between T and 
androstenedione	(r	=	.76,	p	<	.05),	but	not	between	P4 with andros-
tenedione. hCG treatment induced two additional positive correla-
tions	between	androstenedione	with	11-	DOC	(r	=	.84,	p < .01) and 
F I G U R E  2 RU-	486	treatment	
attenuates	hCG-	induced	reversal	
of circulating testosterone plasma 









analyses were performed using the Tukey 
multiple	comparison	test	(p	<	.05;	letters	
indicate differences between treatment 
groups	and	pre-	and	post-	injury	days).	
Differences	between	RU-	486-	induced	
changes in plasma hormones between 
treatment	groups	in	Figures	1	and	2	are	
illustrated	by	(1)	vertical	lines	represent	an	





RU-486 + Sham + saline RU-486 + CCI + salineBaseline






















































































































































p	 <	 .001;	 Table	 3),	 as	 well	 as	 the	 loss	 of	 significant	 correlations	
between	 sex	 steroids.	Unlike	 sham	 injury,	CCI	 injury	 resulted	 in	 a	
strong correlation between androstenedione with its metabolite T 
(r	=	.97,	p	<	.001).	Like	Sham	animals,	hCG	treatment	of	CCI	animals	








hCG	 is	 effective	 in	 reversing	 hypogonadism	 (Figure	 1A,B)	 and	 at-
tenuating	hypoadrenalism	(Figure	1C,D)	following	a	craniectomy	or	
craniectomy	+CCI	injury	in	young	adult	male	rats.	Both	craniectomy	









tomy53–	58 or treatment59,60 has been shown to impair cognition in ro-
dents,	while	lowering	LH	or	blocking	LHCGR	signalling	is	protective	
of memory in rodents53,54,56–	58,60–	63 and humans.35	Conversely,	one	
study has demonstrated that intracerebroventricular hCG delivery 
after	 OVX	 rescued	 dendritic	 spine	 density	 and	 spatial	 memory.64 
The	general	negative	 impact	of	LH/hCG	on	cognitive	performance	
appears	 to	 be	 dependent	 upon	 the	 ratio	 of	 gonadotropins	 to	 sex	
steroids	since	situations	where	gonadotropins	and	sex	steroids	are	
in balance such as during the adult reproductive period65 are pe-
riods of normal cognitive performance and do not involve dyotic 
signalling.32– 34 This is illustrated by the findings that interventions 
that	 reverse	dyotic	 signalling	 such	as	 sex	 steroid	 supplementation	
of	 ovariectomized	 animals	 (see	 references	 above),	 GnRH	 agonist	
suppression	 of	 gonadotropins	 in	 post-	menopausal	 women35 and 
caloric	 restriction	 (eg	Ref.	66),	 either	 reverse	or	halt	 cognitive	de-
cline.	 Therefore,	 one	 might	 predict	 that	 functioning	 gonads	 are	
essential	for	hCG	to	promote	cognitive	recovery	from	a	TBI,	as	we	
have found in intact male rats67	(unpublished	data).	Thus,	hCG	treat-
ment	might	 be	 expected	 to	be	most	 beneficial	 in	 pre-	menopausal	
and	pre-	andropausal	individuals,	while	those	further	along	the	post-	
reproduction spectrum might benefit most from a combination ther-
apy	of	hCG	supplemented	with	appropriate	sex	steroids.
4.1  |  Causes of craniectomy and CCI injury induced 
hypogonadism and hypoadrenalism
The induction of hypogonadism and hypoadrenalism in young male 
rats	following	a	craniectomy	and	a	craniectomy	+CCI	injury	(reduc-
tion in plasma concentrations of P4,	T,	11-	DOC	and	corticosterone;	
Figure	1)	is	consistent	with	previous	reports	in	rats.53,68	Since	hCG	
reversed	hypogonadism	and	diminished	hypoadrenalism	in	Sprague-	
Dawley	rats	 (Figures	1	and	2,	Tables	1–	3),	our	 results	suggest	 iso-
flurane and/or surgical trauma/stress to the HP are impacting the 
long-	term	hypothalamic	release	of	GnRH	or	the	pituitary	release	of	
gonadotropins rather than the production of steroids by the tes-
tes	 (or	 adrenals).	 Circulating	 cortisol	 concentrations	 are	 elevated	
following	neurosurgical	procedures	 in	humans,69–	71 but not during 
TA B L E  1 The	relationship	between	the	concentrations	of	plasma	steroids	in	rats
All groups and time points (PSD/PID 1, 11, 19 and 29)














































    |  7 of 11GEDDES Et al.
anaesthesia	(nitrous	oxide	and	halothane,	after	thiopentone	induc-
tion).	Alternatively,	or	in	conjunction,	isoflurane	anaesthesia	admin-
istered during the craniectomy may have inhibited hypothalamic 
and/or pituitary function since it has been reported that isoflurane 




another complication of anaesthesia that could impact the recovery 
from and quality of life for those undergoing anaesthesia for a sur-
gical	procedure.	Further	research	 is	 required	to	delineate	whether	
this effect is attributed to isoflurane on the functioning of the hypo-
thalamus	and/or	pituitary,	a	combination	of	 isoflurane	and	surgical	
stress or an effect of isoflurane early and of surgical stress later in 
the maintenance of the hypogonadism over 29 days.
Our	 data	 are	 consistent	with	 early	 studies	 in	 humans	 demon-
strating	 that	TBI	could	alter	hypothalamic	morphology	and	 induce	
hypogonadism and hypothyroidism.76,77	However,	while	 our	 study	
implicates isoflurane in the induction of hypogonadism and hypo-
pituitarism	via	suppression	of	HP	function,	human	studies	suggest	
that	 TBI-	induced	 hypogonadism	 and	 hypopituitarism	 is	 mediated	
via suppression of HP function by elevated circulating cortisol.78,79 
Ranganathan et al.79	demonstrated	that	the	stress	of	TBI	results	in	
anovulation	 and	 central	 hypothalamic-	pituitary-	ovarian	 axis	 sup-
pression,	 with	 menstruation	 resuming	 among	 pre-	menopausal	
women	when	serum	cortisol	normalized	to	luteal	phase	control	lev-
els.	 It	 is	 apparent	 that	TBI-	induced	HH,	 even	when	 limited	 to	 the	




as	has	been	reported	for	human	TBI.6–	8,10,14,76–	78,82–	96 These results 
demonstrate that future studies need to take into account the ef-
fects	of	isoflurane	alone	in	any	model	of	TBI-	induced	hypogonadism.
TA B L E  2 The	relationship	between	the	concentrations	of	plasma	steroids	in	Sham	surgery	rats	treated	with	or	without	hCG
Sham + Saline (PSD 1, 11, 19 and 29)














































TA B L E  3 The	relationship	between	the	concentrations	of	plasma	steroids	in	CCI-	injured	rats	treated	with	or	without	hCG
CCI + Saline (PID 1, 11, 19 and 29)
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tomy and/or isoflurane anaesthesia indicates the utility of hCG for 
reversing hypogonadism and hypoadrenalism in these conditions. 
hCG treatment comes with the advantage of not only increasing 
neurotropic	hCG/LH,	but	also	increasing	the	dozens	of	gonadal	sex	
steroid and protein hormones that regulate normal brain structure 
and function.32
hCG has been shown to increase T production in aged male 
rats.97,98	hCG	is	a	safe,	cheap,	FDA-	approved	treatment	for	hypogo-
nadism	in	men	(chronically),	infertility	in	men	and	women,	and	to	pro-
mote the descent of testicles in young boys with cryptorchidism.99	In	
this	context,	hCG	treatment	has	recently	been	shown	to	be	effective	
in	 (1)	 raising	plasma	T	concentrations	 in	healthy	men	with	chronic	
spinal	cord	injury,	and	this	was	not	significantly	different	from	hCG’s	
elevation	 of	 plasma	 T	 in	 able-	bodied	male	 control	 subjects,100	 (2)	
protecting the rodent adult37,38	 and	 neonatal	 brain	 from	 hypoxic-	











that enhanced ovarian oestrogen synthesis causes increased secre-
tion	 of	 prolactin,	which	 elevates	 LHCGR	expression	 in	 the	mouse	
adrenal	 cortex,	 leading	 to	elevated,	LH-	dependent,	 corticosterone	
production.102	 Continuous	 exposure	 to	 hCG	 is,	 however,	 known	
to	 suppress	 the	 expression	 of	 LHCGR	 via	 the	 down-	regulation	 of	
mRNA	(eg	Ref.	103,104).	To	circumvent	the	down-	regulation	of	the	
receptor,	in	our	study	hCG	was	administered	in	the	form	of	Pregnyl	
every	other	day,	 as	 is	used	clinically.105	Since	 initial	phase	half-	life	
of	urinary-	derived	Pregnyl	 is	between	5.6	and	11	h	 (https://www.
merck.ca/),	the	48	h	between	doses	appears	sufficient	to	maintain	
LHCGR	 expression,	 as	 circulating	 concentrations	 of	 sex	 steroids	
(Figure	1A,B)	were	sustained	over	the	29-	day	experiment.
4.3  |  RU- 486 impact on plasma steroid 
concentrations
Elevations	 in	 circulating	 corticosterone	observed	 in	our	 study	 fol-
lowing	 RU-	486	 treatment	 are	 consistent	 with	 elevations	 in	 cor-
ticosterone in the male rats106	 and	 cortisol,	 corticotropin	 or	
adrenocorticotropic	hormone	that	is	observed	in	human	men,107,108 
women,108,109	 and	 non-	human	 primates	 (Macaca fascicularis110). 
Blocking	glucocorticoid	and	P4	signalling	using	RU-	486	had	little	ef-
fect	on	sex	steroid	changes	 induced	by	craniectomy	 (uninjured)	or	
CCI	 injury,	but	significantly	diminished	 the	decline	 in	11-	DOC	and	
corticosterone	 concentrations	 in	 craniectomy	 (uninjured)	 but	 not	
CCI-	injured	 animals	 (Figure	 2A–	D),	 indicating	 that	 blocking	 gluco-
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